Monoclonal antibody aggregation intermediates visualized by atomic force microscopy

Journal of Pharmaceutical Sciences

Volumn 100, Issue 2, 2011, Pages 416-423

  Lee, Hanjoo ^a   Kirchmeier, Marc ^a   Mach, Henryk ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Analytical biochemistry; Bioanalysis; Diffusion; Immunology; Injectables; Protein binding; Protein delivery; Protein folding refolding; Protein formulation; Protein structure

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; MONOMER; OLIGOMER;

ANTIBODY STRUCTURE; ARTICLE; ATOMIC FORCE MICROSCOPY; OLIGOMERIZATION; POLYMERIZATION; PROTEIN AGGREGATION;

EID: 78650529489     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22279     Document Type: Article

References (30)

1. Wang W. 2005. Protein aggregation and its inhibition in biopharmaceuticals. Int J Pharm 289:1-30.
2. Chi EY, Krishan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in non-native protein aggregation. Pharm Res 20:1325-1336.
3. Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G, Fan Y-X, Kirshner S, Verthelyi D, Kozlowski S, Clouse KA, Swann PG, Rosenberg A, Cherney B. 2008. Overlooking subvisible particles in therapeutic protein products: Gaps that may compromise protein quality. J Pharm Sci 98:1201-1205.
4. Howard W, Timasheff SN. 1987. Quasi-elastic light-scattering studies of tubulin aggregation. Arch Biochem Biophys 255:446-452.
5. Goldberg ME, Rudolph R, Jaenicke R. 1991. A kinetic study of competition between renaturation and aggregation during the refolding of denatured reduced egg-white lysozyme. Biochemistry 30:2790-2797.
6. De Young LR, Dill KA, Fink AL. 1993. Aggregation and denaturation of apomyoglobin in aqueous urea solutions. Biochemistry 32:3877-3886.
7. Weiss WF, Young TM, Roberts CJ. 2009. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. J Pharm Sci 98:1246-1277.
8. Fradkin AH, Carpenter JF, Randolph TW. 2009. Immunogenicity of aggregates of recombinant human growth hormone in mouse models. J Pharm Sci 98:3247-3264.
9. Kuman V, Sharma VK, Kalonia DS. 2009. Effect of polyols on polyethylene glycol (PEG)-induced precipitation of proteins. Impact on solubility, stability and conformation. Int J Pharm 366:38-43.
10. Bajaj H, Sharma V, Kalonia DS. 2004. Determination of second virial coefficient of proteins using a dual-detector cell for simultaneous measurement of scattered light intensity and concentration in SEC-HPLC. Biophys J 87:4048-4055.
11. Jacobs A, Hartman K, Laue T, Caffrey M. 2004. Sedimentation velocity studies of the high-molecular weight aggregates of the HIV gp41 ectodomain. Protein Sci 13:2811-2813.
12. Mahler H-C, Freiss W, Graushopf U, Kiese S. 2009. Protein aggregation: Pathways, induction factors and analysis. J Pharm Sci 98(8):2909-2934.
13. Wehr T, Rodriquez-Diaz R. 2005. Use of size exclusion chromatography in biopharmaceutical development. In Analytical techniques for biopharmaceutical development; Rodriquez-Diaz R, Wehr T, Tuck S, Eds. 1st ed, New York: Marcel Dekker, Inc., pp 95-112.
14. Gabrielson JP, Brader ML, Pekar AH, Mathis KB, Winter G, Carpenter JF, Randolph TW. 2007. Quantitation of aggregate levels in recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field fractionation, and sedimentation velocity. J Pharm Sci 96:268-279.
15. Tatford OC, Gomme PT, Bertolini J. 2004. Analytical techniques for the evaluation of liquid protein therapeutics. Biotechnol Appl Biochem 40:67-81.
16. Ahrer K, Buchacher A, Iberer G, Josic D, Jungbauer A. 2003. Analysis of aggregates of human immunoglobulin G using size-exclusion chromatography, static and dynamic light scattering. J Chromatogr A 1009:89-96.
17. Clodfelter DK, Nussbaum MA, Reilly J. 1999. Comparison of free solution capillary electrophoresis and size exclusion chromatography for quantitating non-covalent aggregation of an acylated peptide. J Pharm Biomed Anal 19:763-775.
18. Laue TM, Stafford WF. 1999. Modern applications of analytical ultracentrifugation. Annu Rev Biophys Biomol Struct 28:75-100.
19. Huang C-T, Sharma D, Oma P, Krishnamurthy R. 2008. Quantitation of protein particles in parenteral solutions using micro-flow imaging. J Pharm Sci 98:3058-3071.
20. Johnson JC, Nettikadan SR, Vengasandra SG, Henderson E. J Biochem Biophys Methods Analysis of solid-phase immobilized antibodies by atomic force microscopy. 2004, 59, 167-180.
21. Thomson NH. 2005. Imaging the substructure of antibodies with tapping-mode AFM in air: the importance of a water layer on mica. J Microscopy 217:193-199.
22. Xu H, Zhao X, Grant C, Lu RJ. 2006. Orientation of a monoclonal antibody adsorbed at the solid/solution interface: A combined study using atomic force microscopy and neutron reflectivity. Langmuir 22:6313-6320.
23. Czajkowsky DM, Shao Z. 2009. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proc Natn Acad Sci 106:14960-14965.
24. Wang X, Wang Y, Xu H, Shan H, Lu JR. 2008. Dynamic adsorption of monoclonal antibody layers on hydrophilic silica surface: A combined study by spectrscopic ellipsometry and AFM. J Colloid Interface Sci 323:18-25.
25. Heuser J. 1989. Protocol for 3-D visualization of molecules on mica via the quick-freeze, deep-etch technique. J Electron Microsc Tech 13:244-263.
26. Taschner N. Muller SA, Alumella VR, Goldie KN, Drake AF, Aebi AF, Arvinte T. 2001. Modulation of antigenicity related to changes in antibody flexibility upon lyophilization. J Mol Biol 310:169-179.
27. Mach H. 2003. Unpublished data.
28. Capelle MAH, Brugger P, Arvinte T. 2004. Spectroscopic characterization of antibodies absorbed to aluminum adjuvants: Correlation with antibody vaccine immunogenicity. Vaccine 23:1686-1694.
29. Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. 2009. Design of therapeutic proteins with enhanced stability. Proc Natl Acad Sci U S A 106:11937-11942.
30. Vasco F, Hawe A, Jiskoot W. 2010. Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates [published online March 4, 2010]. Pharm Res. doi:10.1007/s11095-010-0073-2.